Millions of people living with type 1 diabetes around the world don't have reliable access to insulin. Due to their bodies' inability to produce the hormone, they have to inject it to ensure that glucose can enter cells to produce energy. But finding an affordable and reliable source of insulin has remained difficult in many
LIVONIA — Hygieia, a provider of digital therapeutics for insulin management, has added Metro Detroit Endocrinology Center in Dearborn as a clinical partner. The partnership extends Hygieia’s d-Nav network and makes autonomous insulin therapy service available for underserved populations. The unique d-Nav Insulin Management Program uses AI-powered technology to prescribe the appropriate insulin dose each
LIVONIA – Hygieia, a digital therapeutics company for insulin therapy, has appointed Doug Lawrence its chief executive officer, responsible for leading operations, development, and global growth of the company and its d-Nav Insulin Management Program. Lawrence brings three decades of medical technology leadership to his new role at Hygieia, including significant experience bringing products to
ANN ARBOR - Eran Bashan, CEO of Hygieia, explains how his d-Nav program takes the guesswork out of insulin dosing for people who inject daily. It automates insulin dose prescribing using AI and patented technology in an FDA-cleared mobile app. The program includes clinical care support either virtually, or in a Hygieia clinic. The app
LIVONIA - With coronavirus infection rates fluctuating throughout the United States, millions of people with Type 2 diabetes and uncontrolled blood sugar levels remain at elevated risk for serious complications from the disease. In response, physician specialists and scientists from Hygieia have introduced a fully virtual option for their d-Nav® Insulin Management Program. “Ninety percent
LIVONIA - Digital Insulin enhancement company, Hygieia, has cut a three-year deal with Blue Cross Blue Shield of Michigan to make its Nav Insulin Guidance Service available at no cost and with no co-pays to BCBSM members with Type 2 diabetes, starting with at-risk populations in Southeast Michigan. Financial terms were not disclosed. The agreement
ANN ARBOR – Hygieia, a digital insulin enhancement company, announced that it has signed a distribution agreement with Spirit Healthcare, Ltd. to expand accessibility to the d-Nav Insulin Guidance Service across the United Kingdom. Under the agreement, Spirit will license and become a local distributor of the d-Nav Service and other tools developed by Hygieia
